Bio-Rad Laboratories Inc (BIO)
275.89
+0.29
(+0.11%)
USD |
NYSE |
Apr 26, 16:00
275.89
0.00 (0.00%)
After-Hours: 20:00
Bio-Rad Laboratories SG&A Expense (Quarterly): 207.15M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 207.15M |
September 30, 2023 | 201.20M |
June 30, 2023 | 207.82M |
March 31, 2023 | 225.55M |
December 31, 2022 | 212.23M |
September 30, 2022 | 211.11M |
June 30, 2022 | 207.79M |
March 31, 2022 | 196.69M |
December 31, 2021 | 221.69M |
September 30, 2021 | 216.15M |
June 30, 2021 | 213.42M |
March 31, 2021 | 225.85M |
December 31, 2020 | 217.68M |
September 30, 2020 | 198.16M |
June 30, 2020 | 189.26M |
March 31, 2020 | 193.69M |
December 31, 2019 | 214.16M |
September 30, 2019 | 201.62M |
June 30, 2019 | 201.26M |
March 31, 2019 | 207.58M |
December 31, 2018 | 214.03M |
September 30, 2018 | 201.20M |
June 30, 2018 | 210.42M |
March 31, 2018 | 209.13M |
December 31, 2017 | 201.73M |
Date | Value |
---|---|
September 30, 2017 | 198.17M |
June 30, 2017 | 212.49M |
March 31, 2017 | 194.40M |
December 31, 2016 | 217.99M |
September 30, 2016 | 201.45M |
June 30, 2016 | 205.54M |
March 31, 2016 | 189.72M |
December 31, 2015 | 193.14M |
September 30, 2015 | 187.44M |
June 30, 2015 | 192.84M |
March 31, 2015 | 188.56M |
December 31, 2014 | 207.54M |
September 30, 2014 | 202.55M |
June 30, 2014 | 195.84M |
March 31, 2014 | 202.28M |
December 31, 2013 | 214.58M |
September 30, 2013 | 202.24M |
June 30, 2013 | 195.33M |
March 31, 2013 | 185.92M |
December 31, 2012 | 188.86M |
September 30, 2012 | 160.13M |
June 30, 2012 | 162.26M |
March 31, 2012 | 171.29M |
December 31, 2011 | 174.61M |
September 30, 2011 | 176.87M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
189.26M
Minimum
Jun 2020
225.85M
Maximum
Mar 2021
208.55M
Average
207.82M
Median
Jun 2023
SG&A Expense (Quarterly) Benchmarks
Agilent Technologies Inc | 396.00M |
Bruker Corp | 211.80M |
Azenta Inc | 78.58M |
Harvard Bioscience Inc | 11.51M |
Bionano Genomics Inc | 15.69M |